{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T05:29:12Z","timestamp":1762579752355,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.pcl.2025.08.013","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:46:24Z","timestamp":1758987984000},"page":"131-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Pediatric Clinicians in the Diagnosis, Management, and Referral of Priapism in Children and Adolescents with Sickle Cell Disease"],"prefix":"10.1016","volume":"73","author":[{"given":"Ibrahim Musa","family":"Idris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail Isah","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Louis","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2025.08.013_bib1","first-page":"10","article-title":"The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients and non-ischemic priapism: an AUA\/SMSNA guideline","volume":"10","author":"Bivalacqua","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/hematology.2022000380","article-title":"Epidemiology and treatment of priapism in sickle cell disease","volume":"2022","author":"Idris","year":"2022","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.pcl.2025.08.013_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European association of urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2019.11.013","article-title":"Rare disorders of penile erection","volume":"113","author":"Burnett","year":"2020","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.pcl.2025.08.013_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.pcl.2025.08.013_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3324\/haematol.11474","article-title":"Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe","volume":"92","author":"Roberts","year":"2007","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.pcl.2025.08.013_bib7","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/bloodadvances.2020002062","article-title":"Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease","volume":"4","author":"Idris","year":"2020","journal-title":"Blood Adv"},{"issue":"20","key":"10.1016\/j.pcl.2025.08.013_bib8","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1182\/bloodadvances.2022007285","article-title":"Incidence and predictors of priapism events in a sickle cell anemia: a diary-based analysis","volume":"6","author":"Idris","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.pcl.2025.08.013_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1464-4096.2001.01510.x","article-title":"Low-flow priapism: risk factors for erectile dysfunction","volume":"89","author":"El-Bahnasawy","year":"2002","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.pcl.2025.08.013_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jsm.12816","article-title":"Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors","volume":"12","author":"Anele","year":"2015","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.ju.0000046303.22757.f2","article-title":"Pathophysiology of priapism: dysregulatory erection physiology thesis","volume":"170","author":"Burnett","year":"2003","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.pcl.2025.08.013_bib12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/1389450115666141111111842","article-title":"Molecular pathophysiology of priapism: emerging targets","volume":"16","author":"Anele","year":"2014","journal-title":"Curr Drug Targets"},{"issue":"4","key":"10.1016\/j.pcl.2025.08.013_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ucl.2005.08.007","article-title":"Physiology of penile erection and pathophysiology of erectile dysfunction","volume":"32","author":"Dean","year":"2005","journal-title":"Urol Clin North Am"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1743-6109.2011.02287.x","article-title":"Priapism in sickle-cell disease: a hematologist\u2019s perspective","volume":"9","author":"Kato","year":"2012","journal-title":"J Sex Med"},{"issue":"5","key":"10.1016\/j.pcl.2025.08.013_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","article-title":"Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape","volume":"24","author":"Musicki","year":"2020","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.pcl.2025.08.013_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.61386\/imj.v7i2.420","article-title":"Aetiology of sickle cell ischemic priapism: the pathophysiologic triad of hyperhaemolysis, hyperviscosity and hypercoagulability, and their therapeutic implications","volume":"17","author":"Ahmed","year":"2024","journal-title":"Ibom Med Journal"},{"issue":"2","key":"10.1016\/j.pcl.2025.08.013_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jsxm.2020.11.010","article-title":"Rare disorders of painful erection: a cohort study of the investigation and management of stuttering priapism and sleep-related painful erection","author":"Johnson","year":"2021","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/FAD.0000000000000048","article-title":"Drug-induced priapism","volume":"322","author":"Pucci","year":"2020","journal-title":"Adverse Drug React Bull"},{"issue":"2","key":"10.1016\/j.pcl.2025.08.013_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.sxmr.2018.09.002","article-title":"Unintended consequences: a review of pharmacologically-induced priapism","volume":"7","author":"Scherzer","year":"2019","journal-title":"Sex Med Rev"},{"issue":"4","key":"10.1016\/j.pcl.2025.08.013_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ajhp\/61.4.355","article-title":"Treatment of priapism in pediatric patients with sickle cell disease","volume":"61","author":"Maples","year":"2004","journal-title":"Am J Heal Syst Pharmacy"},{"issue":"5 I","key":"10.1016\/j.pcl.2025.08.013_bib21","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0022-5347(17)35817-2","article-title":"Association of sickle cell disease, priapism, exchange transfusion and neurological events: aspen syndrome","volume":"150","author":"Siegel","year":"1993","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.pcl.2025.08.013_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(05)81954-7","article-title":"Neurologic events after partial exchange transfusion for priapism in sickle cell disease","volume":"120","author":"Rackoff","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.pcl.2025.08.013_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/asheducation-2013.1.439","article-title":"Transfusion therapy for sickle cell disease: a balancing act","volume":"2013","author":"Chou","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"10","key":"10.1016\/j.pcl.2025.08.013_bib24","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.jsxm.2021.07.006","article-title":"Exploring the use of exchange transfusion in the surgical management of priapism in sickle cell disease: a population-based analysis","volume":"18","author":"Ha","year":"2021","journal-title":"J Sex Med"},{"issue":"23","key":"10.1016\/j.pcl.2025.08.013_bib25","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1182\/blood-2014-09-551887","article-title":"How i treat how i treat priapism","volume":"125","author":"Anele","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood.V95.1.78","article-title":"Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism","volume":"95","author":"Mantadakis","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pcl.2025.08.013_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bju.13717","article-title":"Guideline of guidelines: priapism","volume":"119","author":"Muneer","year":"2017","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.pcl.2025.08.013_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2164\/jandrol.110.010934","article-title":"A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial--the priapism in sickle cell study","volume":"32","author":"Olujohungbe","year":"2011","journal-title":"J Androl"},{"key":"10.1016\/j.pcl.2025.08.013_bib29","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-5347(17)35111-X","article-title":"Oral terbutaline for the treatment of priapism","volume":"151","author":"Govier","year":"1994","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.pcl.2025.08.013_bib30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1743-6109.2006.00333.x","article-title":"Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism","volume":"3","author":"Burnett","year":"2006","journal-title":"J Sex Med"},{"issue":"7","key":"10.1016\/j.pcl.2025.08.013_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"27","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"issue":"26","key":"10.1016\/j.pcl.2025.08.013_bib32","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.2024027898","article-title":"A controlled trial for preventing priapism in sickle cell anemia: hydroxyurea plus placebo vs hydroxyurea plus tadalafil","volume":"145","author":"Idris","year":"2025","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pcl.2025.08.013_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.pcl.2025.08.013_bib34","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2352-3026(23)00096-0","article-title":"Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission","volume":"10","author":"Piel","year":"2023","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20142","article-title":"Follow-up of sickle cell disease patients with priapism treated by hydroxyurea","volume":"77","author":"Saad","year":"2004","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.pcl.2025.08.013_bib36","first-page":"518","article-title":"Effect of hydroxyurea on priapism in men with sickle cell disease","volume":"66","author":"Morrison","year":"2017","journal-title":"West Indian Med J"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib37","first-page":"126","article-title":"Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment","volume":"129","author":"Berthaut","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pcl.2025.08.013_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/17474086.2014.959922","article-title":"Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review","volume":"7","author":"Debaun","year":"2014","journal-title":"Expert Rev Hematol"},{"issue":"8467","key":"10.1016\/j.pcl.2025.08.013_bib39","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(85)91555-7","article-title":"Stilboestrol and stuttering priapism in homozygous sickle-cell disease","volume":"326","author":"Serjeant","year":"1985","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pcl.2025.08.013_bib40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1590\/S1677-55382012000500014","article-title":"Finasteride for recurrent priapism in children and adolescents : a report on 5 cases","volume":"38","author":"Barroso","year":"2012","journal-title":"Int Braz J Urol"},{"issue":"5","key":"10.1016\/j.pcl.2025.08.013_bib41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.urology.2009.04.071","article-title":"Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach","volume":"74","author":"Rachid-filho","year":"2009","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.21037\/tau.2019.07.15","article-title":"Dutasteride in the long-term management of stuttering priapism","volume":"9","author":"Baker","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.pcl.2025.08.013_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jsm.12359","article-title":"Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes","volume":"11","author":"Hoeh","year":"2014","journal-title":"J Sex Med"},{"issue":"142","key":"10.1016\/j.pcl.2025.08.013_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/blood-2023-179042","article-title":"Primary analysis of spartan: a phase 2 trial to assess the efficacy and safety of crizanlizumab in patients with sickle cell disease related priapism","volume":"28","author":"Idowu","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pcl.2025.08.013_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395525001154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395525001154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T05:24:38Z","timestamp":1762579478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395525001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0031395525001154"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2025.08.013","relation":{},"ISSN":["0031-3955"],"issn-type":[{"type":"print","value":"0031-3955"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Pediatric Clinicians in the Diagnosis, Management, and Referral of Priapism in Children and Adolescents with Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2025.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}